Status:
COMPLETED
Oral Dexmedetomidine vs Midazoam For Premedication
Lead Sponsor:
Aydin Adnan Menderes University
Conditions:
Premedication
Eligibility:
All Genders
3-7 years
Phase:
PHASE4
Brief Summary
The aim of this study was to compare the effect of 2 µg/kg of oral dexmedetomidine (DEX) and 0.5 mg/kg dormicum as premedication among children undergoing dental procedures.
Detailed Description
The study involved 52 children between 3-7 years of age, ASA I , who underwent full-mouth dental rehabilitation. The DEX group (n=26) received 2 µg/kg DEX in apple juice, and the control group (n=26) ...
Eligibility Criteria
Inclusion
- The inclusion criteria is age between 3 to 7 years and American Society og Anesthesiology (ASA) grade 1.
Exclusion
- The exclusion criteria included congenital disease, DEX, propofol allergy, asthma, mental retardation and those children parents refuse to participate study.
Key Trial Info
Start Date :
November 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT03357718
Start Date
November 1 2016
End Date
June 1 2017
Last Update
May 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.